![Carl Blobel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Carl Blobel
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
SciRhom GmbH
![]() SciRhom GmbH Miscellaneous Commercial ServicesCommercial Services SciRhom GmbH engages in the development of treatment for life-threatening diseases. The company was founded by Andreas Jenne, Jens Ruhein, Axel Ullrich, Carl Blobel and Matthias Schneider in 2016 and is headquartered in Planegg, Germany.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Carl Blobel tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
PATRYS LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
U3 Pharma AG
![]() U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Founder | |
Max-Planck-Institute for Molecular Genetics | College/University | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
University of Osnabrück | College/University | Graduate Degree | |
Universität Ulm | College/University | Doctorate Degree | |
Evotec (München) GmbH
![]() Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | Chemicals: Major Diversified | Founder Chief Executive Officer | |
RSP Systems A/S
![]() RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Medical Specialties | Chief Executive Officer | |
Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree | |
Patrys GmbH | Chief Executive Officer | ||
NEO New Oncology GmbH
![]() NEO New Oncology GmbH Medical/Nursing ServicesHealth Services NEO New Oncology GmbH provides molecular diagnostics-based services. Its cancer genome diagnostic platform include The NEO Technology, NEOplus and NEOliquid which support pathologists and oncologists with comprehensive molecular information to help select targeted cancer therapies. The company was founded by Roman Thomas and Axel Ullrich in 2012 and is headquartered in Cologne, Germany. | Medical/Nursing Services | Founder Chief Executive Officer | |
CYXONE AB | Pharmaceuticals: Major | Director/Board Member | |
Mecuris GmbH
![]() Mecuris GmbH Commercial Printing/FormsCommercial Services Mecuris GmbH operates a software platform for automatic generation of patient-customized orthoses and prosthetic designs. The company was founded by Manuel Opitz, Wolf-Peter Werner, Felix Gundlack, Jannis Breuninger and Simon Weidert and is headquartered in Munich, Germany. | Commercial Printing/Forms | Director/Board Member | |
Mogling Bio
![]() Mogling Bio BiotechnologyHealth Technology Mogling Bio operates as a biotechnology company. The company is based in Wilmington, DE. The company was founded by Jürgen Reess. Jürgen Reess has been the CEO since incorporation. | Biotechnology | Chief Executive Officer | |
Cellerys AG
![]() Cellerys AG Miscellaneous Commercial ServicesCommercial Services Cellerys AG is a Swiss company that is focused on reinventing MS therapy. The private company is based in Schlieren, Switzerland. The phase I trial showed excellent tolerability and safety and indicated the induction of several tolerance mechanisms. The company was founded in 2015 as a spin-out from the University of Zurich, where it conducted a successful phase I clinical trial with the support of Wyss Zurich, a joint accelerator of the University of Zurich and ETH Zurich. | Miscellaneous Commercial Services | Chief Executive Officer | |
High-Tech Gründerfonds Management GmbH
![]() High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistiche
Distribuzione geografica
Germania | 14 |
Stati Uniti | 4 |
Australia | 3 |
Danimarca | 2 |
Svezia | 2 |
Settori
Health Technology | 8 |
Consumer Services | 6 |
Commercial Services | 5 |
Distribution Services | 2 |
Process Industries | 2 |
Posizioni
Founder | 11 |
Chief Executive Officer | 7 |
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 3 |
Contatti più connessi
Insiders | |
---|---|
Axel Ullrich | 9 |
Frank Hensel | 8 |
Andreas Jenne | 6 |
Jürgen Reess | 5 |
Jens Ruhe | 1 |
Matthias Schneider | 1 |
- Borsa valori
- Insiders
- Carl Blobel
- Connessioni Società